APOE mice heterozygous for ATM display accelerated metabolic syndrome and atherosclerosis, indicating that genetic suppression of the ATM-AMPK pathway contributes to the development of dysfunction [41]. The gene discussed is PRKAA2; the disease is metabolic syndrome.